For laboratory research use only — not for human or veterinary consumption.
The Peptide Index
Dosing guide

SLU-PP-332 Dosage Chart & Schedule

SLU-PP-332 is a small-molecule agonist of the estrogen-related receptors investigated as an exercise-mimetic candidate that increases oxidative metabolism and endurance in rodents. Despite being frequently grouped with research peptides, it is not a peptide. Evidence is preclinical with no human data, and it is not approved.

Route
Oral
Frequency
No human dosing
Half-life
Reported short systemic exposure in rodent studies
Storage
Laboratory chemical; store cool and dry.
The short answer

SLU-PP-332 is a small-molecule estrogen-related-receptor agonist studied as an exercise-mimetic candidate, and despite being grouped with research peptides it is not a peptide. Evidence is rodent-stage only, where it was given by injection at about 50 mg/kg; there is no human data and no established human or oral dose.

Figures describe how SLU-PP-332 is reported in the research literature and research-community references — not a recommendation for human use. For laboratory research only.

Dosage protocols

Commonly referenced research tiers. Start conservative; every compound and study context differs.

Most commonStandard
No human dose
Rodent studies used about 50 mg/kg by injection
Frequency
Not established in humans
Weekly total
Not established in humans
Cycle
Preclinical (rodent) only

Not a peptide; a small-molecule ERR agonist with no human data.

Not a peptide, and rodent-stage

  • SLU-PP-332 is a small-molecule agonist of the estrogen-related receptors, not a peptide.
  • Evidence is preclinical in rodents, where it was given by injection (about 50 mg/kg).
  • There is no human data and no established human or oral regimen.

Ready to run this protocol?

Dosing is only as good as the vial. Research-grade peptides are third-party tested with published COAs from our top-rated source — reconstitute with confidence and skip the guesswork on identity and purity.

Handling & storage

  • Not a water-reconstituted peptide; it is a small-molecule research chemical.
  • For laboratory use it is typically dissolved in a co-solvent such as DMSO, not bacteriostatic water.
  • No human oral formulation or dose has been established.
  • Evidence is rodent-stage; treat any figure as preclinical context only.

SLU-PP-332 dosing FAQ

Is there a human dose for SLU-PP-332?

No. Evidence is rodent-stage, where it was given by injection at about 50 mg/kg; there is no human data and no established human or oral dose.

Is SLU-PP-332 a peptide?

No. It is a small-molecule agonist of the estrogen-related receptors, often grouped with research peptides but chemically different.

How is it handled in the lab?

As a small-molecule research chemical it is typically dissolved in a co-solvent such as DMSO, not reconstituted with bacteriostatic water for injection.

What is it studied for?

It is an exercise-mimetic candidate that increased oxidative metabolism and endurance in rodents; those findings have not been tested in humans.

Sources

Full SLU-PP-332 reference →All dosing charts →

Categories: GLP-1 & Metabolic · Status: Research use only. This page is educational and for laboratory research use only; it is not medical advice.